Karen M. Sokolov, M.D.
- Assistant Clinical Professor, Department of Radiation Oncology
- Radiation Oncologist
310-792-6539
Karen M. Sokolov, M.D.
Clinical Specialties
- Radiation Oncology
Areas of Expertise
- Stereotactic Brain and Body Radiation (SRS and SBRT)
- Deep Inspiration Breath Hold Technique for Breast Treatment
- Intensity Modulated Radiation Therapy (IMRT)
- Image-Guided Radiation Therapy (IGRT)
- 4D Radiotherapy
Dr. Karen Sokolov is the best doctor I have ever had ... She's super duper nice, friendly and compassionate.” - Patient
Patients rave about the care they've received from Karen Sokolov, M.D., a board-certified radiation oncologist. She joins City of Hope after serving the community of Torrance, California, for the past decade.
A perpetual honors student, Dr. Sokolov received a B.S. in chemistry from UCLA and was named Bruin of The Year. She then earned her medical degree at UC San Francisco (UCSF). She completed her internship at Saint Mary Hospital in Long Beach, California before returning to UCLA for residency in radiation oncology where she rose to the level of Chief Resident.
Dr. Sokolov is experienced in a wide variety of precision radiation systems and equipment, including Stereotactic Brain and Body Radiation (SRS and SBRT), Deep Inspiration Breath Hold technique for breast treatment, Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), and 4D Radiotherapy.
Dr. Sokolov has published a diverse series of papers aimed at improving the effectiveness of various radiation systems.
- 2018 - present, Radiation Oncologist and Assistant Clinical Professor, Department of Radiation Oncology, City of Hope South Bay, Torrance, CA
- 2013 - 2018, Radiation Oncologist, Providence Little Company of Mary Medical Center, Torrance, CA
- 2010-2013, Radiation Oncologist, Torrance Memorial Medical Center Torrance, California
City of Hope South Bay, 5215 Torrance Blvd., Torrance, CA, 90503
Get DirectionsPhone : 310-750-1715
Degrees
- 2005, M.D., University of California San Francisco, San Francisco, CA
- 2001, B.S. Chemistry, University of California Los Angeles, Los Angeles, CA
Residency
- 2009 - 2010, Chief Resident, Radiation Oncology, University of California Los Angeles, Los Angeles, CA
- 2006 - 2009, Resident, Radiation Oncology, University of California Los Angeles, Los Angeles, CA
Internship
- 2005 - 2006, Intern, Internal Medicine, Saint Mary Hospital, Long Beach, CA
Yeh B, Belanto J, Sokolov KM, Pham V, Gobrial M, Mischel P, Jewett A, Jamieson C, Cacalano
N. SOCS5 Is A Potential Tumor Suppressor and Radiation Response Modifier in Glioblastoma.
Translational Advances in Radiation Oncology and Cancer imaging. September 2009. St. Louis.
Sokolov KM, Yeh B, Hagio M, DeMarco J, Lee SP. MRI Based Prostate Delineation Can Improve
the Therapeutic Ratio in the Treatment of Prostate Cancer. Translational Advances in Radiation Oncology and Cancer Imaging. September 2009. St. Louis.
Sokolov KM, Kreye E, Miller LG, Choi C, Tang AW. Postpartum lliopsoas Pyomyositis Due to
Community-Acquired Methicillin Resistant Staphlococcus aureus. Obstetrics and Gynecology. 2007. 110:545-8.
Sokolov KM, Missett B, Xia P, Hsu I, Speight J. Using Intensity Modulated Radiotherapy (IMRT) To Match Brachytherapy Dose Distributions in Cervical Cancer. Nagoya, Japan. December 2004.
N. SOCS5 Is A Potential Tumor Suppressor and Radiation Response Modifier in Glioblastoma.
Translational Advances in Radiation Oncology and Cancer imaging. September 2009. St. Louis.
Sokolov KM, Yeh B, Hagio M, DeMarco J, Lee SP. MRI Based Prostate Delineation Can Improve
the Therapeutic Ratio in the Treatment of Prostate Cancer. Translational Advances in Radiation Oncology and Cancer Imaging. September 2009. St. Louis.
Sokolov KM, Kreye E, Miller LG, Choi C, Tang AW. Postpartum lliopsoas Pyomyositis Due to
Community-Acquired Methicillin Resistant Staphlococcus aureus. Obstetrics and Gynecology. 2007. 110:545-8.
Sokolov KM, Missett B, Xia P, Hsu I, Speight J. Using Intensity Modulated Radiotherapy (IMRT) To Match Brachytherapy Dose Distributions in Cervical Cancer. Nagoya, Japan. December 2004.